oncology

Deep Pharma Intelligence announced the release of AI in Oncology Analytics Platform.

Commercial, rather than patient interests, often drive cancer care and research and patients deserve better, argue a group of global oncologists and patient advocates in a Comment published in The Lancet Oncology journal.

Novigenix SA is a leading data-driven precision medicine biotech that develops and commercialises immuno-transcriptomic precision oncology solutions.

Immune checkpoint inhibitors have become one of the main treatments for patients with metastatic urothelial cancer.